- Home
- ERAS vs VALU Comparison
ERAS vs VALU Comparison
Compare ERAS & VALU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- VALU
- Stock Information
- Founded
- ERAS 2018
- VALU 1931
- Country
- ERAS United States
- VALU United States
- Employees
- ERAS N/A
- VALU 117
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- VALU Investment Managers
- Sector
- ERAS Health Care
- VALU Finance
- Exchange
- ERAS Nasdaq
- VALU Nasdaq
- Market Cap
- ERAS 439.7M
- VALU 365.4M
- IPO Year
- ERAS 2021
- VALU N/A
- Fundamental
- Price
- ERAS $2.44
- VALU $38.84
- Analyst Decision
- ERAS Buy
- VALU
- Analyst Count
- ERAS 6
- VALU 0
- Target Price
- ERAS $3.67
- VALU N/A
- AVG Volume (30 Days)
- ERAS 2.1M
- VALU 4.2K
- Earning Date
- ERAS 11-07-2025
- VALU 12-12-2025
- Dividend Yield
- ERAS N/A
- VALU 3.35%
- EPS Growth
- ERAS N/A
- VALU 6.17
- EPS
- ERAS N/A
- VALU 2.26
- Revenue
- ERAS N/A
- VALU $34,801,000.00
- Revenue This Year
- ERAS N/A
- VALU N/A
- Revenue Next Year
- ERAS N/A
- VALU N/A
- P/E Ratio
- ERAS N/A
- VALU $16.90
- Revenue Growth
- ERAS N/A
- VALU N/A
- 52 Week Low
- ERAS $1.01
- VALU $32.94
- 52 Week High
- ERAS $3.31
- VALU $57.68
- Technical
- Relative Strength Index (RSI)
- ERAS 59.41
- VALU 50.39
- Support Level
- ERAS $2.18
- VALU $38.14
- Resistance Level
- ERAS $2.65
- VALU $40.00
- Average True Range (ATR)
- ERAS 0.15
- VALU 0.73
- MACD
- ERAS -0.03
- VALU -0.09
- Stochastic Oscillator
- ERAS 55.79
- VALU 35.49
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About VALU Value Line Inc.
Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and making available copyright data, including ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets under brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing and a trusted name in Investment Research. Its only operating segment being Publishing.